PA8815101A1 - Asoc. entre unasal de bis-tiazolio o uno de sus precursosres y artemisinina o uno de sus derivados para el trat....... - Google Patents
Asoc. entre unasal de bis-tiazolio o uno de sus precursosres y artemisinina o uno de sus derivados para el trat.......Info
- Publication number
- PA8815101A1 PA8815101A1 PA20098815101A PA8815101A PA8815101A1 PA 8815101 A1 PA8815101 A1 PA 8815101A1 PA 20098815101 A PA20098815101 A PA 20098815101A PA 8815101 A PA8815101 A PA 8815101A PA 8815101 A1 PA8815101 A1 PA 8815101A1
- Authority
- PA
- Panama
- Prior art keywords
- artemisinine
- derivatives
- tiazolio
- bis
- unasal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCIÓN TIENE POR OBJETO UNA ASOCIACIÓN, QUE COMPRENDE UNA SAL DE BISTIAZOLIO, COMPUESTO DE FÓRMULA (VI) O UNO DE SUS PRECURSORES, Y ARTEMISININA O UNO DE SUS DERIVADOS. LA INVENCIÓN TIENE IGUALMENTE POR OBJETO UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE AL MENOS UNA SAL DE BIS-TIAZOLIO, COMPUESTO DE FÓRMULA (VI) O UNO DE SUS PRECURSORES, Y ARTEMISININA O UNO DE SUS DERIVADOS. LA INVENCIÓN TIENE TAMBIÉN POR OBJETO LA UTILIZACIÓN DE DICHA ASOCIACIÓN PARA LA PREPARACIÓN DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO O A LA PREVENCIÓN DEL PALUDISMO GRAVE. LA INVENCIÓN TIENE FINALMENTE POR OBJETO UN KIT PARA EL TRATAMIENTO O LA PREVENCIÓN DEL PALUDISMO GRAVE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800618A FR2926993B1 (fr) | 2008-02-06 | 2008-02-06 | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8815101A1 true PA8815101A1 (es) | 2009-09-17 |
Family
ID=39705083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20098815101A PA8815101A1 (es) | 2008-02-06 | 2009-02-05 | Asoc. entre unasal de bis-tiazolio o uno de sus precursosres y artemisinina o uno de sus derivados para el trat....... |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US8304440B2 (es) |
| EP (1) | EP2252286B1 (es) |
| JP (1) | JP5469095B2 (es) |
| KR (1) | KR20100137442A (es) |
| CN (1) | CN101980706B (es) |
| AP (1) | AP2613A (es) |
| AR (1) | AR070581A1 (es) |
| AT (1) | ATE521347T1 (es) |
| AU (1) | AU2009227092B2 (es) |
| BR (1) | BRPI0907484A2 (es) |
| CA (1) | CA2714184A1 (es) |
| CL (1) | CL2009000264A1 (es) |
| CO (1) | CO6300843A2 (es) |
| CR (1) | CR11613A (es) |
| CY (1) | CY1112113T1 (es) |
| DK (1) | DK2252286T3 (es) |
| EA (1) | EA022711B1 (es) |
| EC (1) | ECSP10010381A (es) |
| ES (1) | ES2372148T3 (es) |
| FR (1) | FR2926993B1 (es) |
| HR (1) | HRP20110858T8 (es) |
| IL (1) | IL207442A0 (es) |
| JO (1) | JO2820B1 (es) |
| MA (1) | MA32128B1 (es) |
| MX (1) | MX2010008653A (es) |
| MY (1) | MY150776A (es) |
| NI (1) | NI201000135A (es) |
| NZ (1) | NZ587232A (es) |
| PA (1) | PA8815101A1 (es) |
| PE (1) | PE20091410A1 (es) |
| PL (1) | PL2252286T3 (es) |
| PT (1) | PT2252286E (es) |
| RS (1) | RS52046B (es) |
| SI (1) | SI2252286T1 (es) |
| TW (1) | TWI402071B (es) |
| UA (1) | UA99510C2 (es) |
| UY (1) | UY31640A1 (es) |
| WO (1) | WO2009115666A2 (es) |
| ZA (1) | ZA201005611B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2951945B1 (fr) * | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
| AU2014346668C1 (en) | 2013-11-08 | 2018-04-26 | Exthera Medical Corporation | Methods for diagnosing infectious diseases using adsorption media |
| US10714230B2 (en) * | 2017-12-06 | 2020-07-14 | C3Nano Inc. | Thin and uniform silver nanowires, method of synthesis and transparent conductive films formed from the nanowires |
| CN110604733A (zh) * | 2019-09-19 | 2019-12-24 | 同济大学 | 青蒿素类药物与其它药物联用在制备抗疟疾药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1058717A (zh) * | 1990-08-08 | 1992-02-19 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗疟新药—复方蒿甲醚及其制备方法 |
| FR2796642B1 (fr) * | 1999-07-21 | 2001-10-19 | Centre Nat Rech Scient | Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire |
| JP2003050535A (ja) * | 2001-08-07 | 2003-02-21 | T-Zone Corp | ネットワーク教育システム、ネットワーク教育方法、および、プログラム |
| FR2884715B1 (fr) * | 2005-04-20 | 2007-06-15 | Sanofi Aventis Sa | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
-
2008
- 2008-02-06 FR FR0800618A patent/FR2926993B1/fr not_active Expired - Fee Related
-
2009
- 2009-02-01 JO JO200952A patent/JO2820B1/en active
- 2009-02-04 PE PE2009000161A patent/PE20091410A1/es not_active Application Discontinuation
- 2009-02-05 ES ES09721879T patent/ES2372148T3/es active Active
- 2009-02-05 MX MX2010008653A patent/MX2010008653A/es active IP Right Grant
- 2009-02-05 BR BRPI0907484A patent/BRPI0907484A2/pt not_active IP Right Cessation
- 2009-02-05 EA EA201070923A patent/EA022711B1/ru not_active IP Right Cessation
- 2009-02-05 AP AP2010005353A patent/AP2613A/xx active
- 2009-02-05 SI SI200930113T patent/SI2252286T1/sl unknown
- 2009-02-05 DK DK09721879.6T patent/DK2252286T3/da active
- 2009-02-05 WO PCT/FR2009/000129 patent/WO2009115666A2/fr active Application Filing
- 2009-02-05 CN CN2009801109704A patent/CN101980706B/zh not_active Expired - Fee Related
- 2009-02-05 AU AU2009227092A patent/AU2009227092B2/en not_active Ceased
- 2009-02-05 CA CA2714184A patent/CA2714184A1/fr not_active Abandoned
- 2009-02-05 CL CL2009000264A patent/CL2009000264A1/es unknown
- 2009-02-05 HR HR20110858T patent/HRP20110858T8/xx unknown
- 2009-02-05 RS RS20110508A patent/RS52046B/en unknown
- 2009-02-05 NZ NZ587232A patent/NZ587232A/en not_active IP Right Cessation
- 2009-02-05 UA UAA201010670A patent/UA99510C2/ru unknown
- 2009-02-05 MY MYPI20103671 patent/MY150776A/en unknown
- 2009-02-05 JP JP2010545524A patent/JP5469095B2/ja not_active Expired - Fee Related
- 2009-02-05 KR KR1020107019691A patent/KR20100137442A/ko not_active Abandoned
- 2009-02-05 PT PT09721879T patent/PT2252286E/pt unknown
- 2009-02-05 PA PA20098815101A patent/PA8815101A1/es unknown
- 2009-02-05 AT AT09721879T patent/ATE521347T1/de active
- 2009-02-05 EP EP09721879A patent/EP2252286B1/fr active Active
- 2009-02-05 PL PL09721879T patent/PL2252286T3/pl unknown
- 2009-02-06 TW TW098103960A patent/TWI402071B/zh not_active IP Right Cessation
- 2009-02-06 UY UY031640A patent/UY31640A1/es not_active Application Discontinuation
- 2009-02-06 AR ARP090100409A patent/AR070581A1/es unknown
-
2010
- 2010-07-29 CR CR11613A patent/CR11613A/es not_active Application Discontinuation
- 2010-08-03 NI NI201000135A patent/NI201000135A/es unknown
- 2010-08-05 EC EC2010010381A patent/ECSP10010381A/es unknown
- 2010-08-05 IL IL207442A patent/IL207442A0/en not_active IP Right Cessation
- 2010-08-05 ZA ZA2010/05611A patent/ZA201005611B/en unknown
- 2010-08-06 CO CO10096216A patent/CO6300843A2/es not_active Application Discontinuation
- 2010-08-06 US US12/851,747 patent/US8304440B2/en not_active Expired - Fee Related
- 2010-09-01 MA MA33132A patent/MA32128B1/fr unknown
-
2011
- 2011-11-24 CY CY20111101156T patent/CY1112113T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123033T1 (el) | Σπειροκυκλικοι αναστολεις της καθεψινης c | |
| SV2018005778A (es) | Derivados aromaticos de sulfonamida | |
| BR112016027041A8 (pt) | combinações farmacêuticas para tratamento do câncer | |
| CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
| UY32730A (es) | Inhibidores de cyp17 | |
| GT201400111A (es) | Triazolopiridinas sustituidas | |
| HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| NI200900184A (es) | Uso de compuestos inhibidores de quinaxolina de pi3k-alfa para el tratamiento del cáncer. | |
| CL2011000933A1 (es) | El compuesto 2-[(5-cloro-2-{[3-metil-1-(1-metiletil)-1h-pirazol-5-il]amino}-4-piridinil)amino]-n-(metiloxi)benzamida y sus sales, inhibidor de la quinasa de adhesion focal (fak); composicion farmaceutica que lo comprende; y su uso para el tratamiento del cancer. | |
| BR112017005242A2 (pt) | composto, composição farmacêutica, e, composto para uso. | |
| AR094707A1 (es) | Compuesto de quinazolin-4-amina, composición farmacéutica que lo comprende y su uso para el tratamiento de una enfermedad mediada por la quinasa rip2 | |
| BR112015026840A2 (pt) | composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia | |
| BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
| BR112015023878A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CL2011000168A1 (es) | Compuestos derivados de narciclasina y pancratistatina; procedimiento de preparación; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento del cáncer. | |
| PA8815101A1 (es) | Asoc. entre unasal de bis-tiazolio o uno de sus precursosres y artemisinina o uno de sus derivados para el trat....... | |
| NO20090234L (no) | Tricyklisk sammensetning og farmasoytisk anvendelse derav | |
| CL2019001618A1 (es) | Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar. | |
| CL2017002229A1 (es) | Inhibidores de bace1. | |
| CO2017001076A2 (es) | Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam | |
| PA8789101A1 (es) | Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble | |
| BR112017005241A2 (pt) | composto, e, composição farmacêutica. | |
| MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
| CL2009001493A1 (es) | Compuestos derivados de 3-cianopirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de infecciones bacterianas. | |
| DOP2010000240A (es) | Asociacion entre una sal de bis-tiazolio o uno de sus precursores y artemisinina o uno de sus derivados para el tratamiento del paludismo grave |